OrbiMed Capital GP VIII LLC's Net Worth
$0
Estimate Recalculated Jan 3, 2025 08:02PM EST
Who is OrbiMed Capital GP VIII LLC?
OrbiMed Capital GP VIII LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ArriVent Biopharma, Inc., Janux Therapeutics, Inc., Decibel Therapeutics, Inc., Kinnate Biopharma Inc., Disc Medicine, Inc., and Traws Pharma, Inc..
SEC CIK
OrbiMed Capital GP VIII LLC's CIK is 0001845804
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ArriVent Biopharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +143.25% | 3.03M |
$18.00 | $3,999,996.00 | 5.14M |
Jan 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Janux Therapeutics, Inc. (JANX) Snapshot price: $42.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.60% | -40.40K |
$20.30 | -$820,120.00 | 2.49M |
Dec 29
| |||
Form 4
| -4.51% | -119.40K |
$19.00 | -$2,268,600.00 | 2.53M |
Dec 21
| |||
Form 4
|
∞
| 3.04M |
$17.00 |
—
| 3.04M |
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Decibel Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +161.61% | 4.95M |
$18.00 | $29,999,988.00 | 8.01M |
Feb 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kinnate Biopharma Inc. (KNTE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -8.01M |
—
|
—
|
0
|
Apr 3
| |||
Form 4
| +21.20% | 1.46M |
$2.78 | $4,086,234.61 | 8.35M |
May 4 - May 5
| |||
Form 4
| +10.11% | 1.41M |
$2.61 | $3,673,900.83 | 15.3M |
Apr 28 - May 2
| |||
Form 4
|
∞
| 1.1M |
—
|
—
| 1.1M |
Feb 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Disc Medicine, Inc. (IRON) Snapshot price: $50.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.90% | 83.33K |
$36.00 | $3,000,024.00 | 1.79M |
Jun 17
| |||
Form 4
|
—
|
0
|
$48.62 | -$36,617.76 |
0
|
Dec 18
| |||
Form 4
| -20.29% | -433.20K |
$56.75 | -$24,584,100.00 | 1.7M |
Dec 14
| |||
Form 4
| -2.11% | -134.20K |
$58.95 | -$7,902,266.00 | 6.23M |
Dec 12 - Dec 14
| |||
Form 4
| +5.03% | 108.7K |
$23.00 | $2,500,008.00 | 2.27M |
Feb 15
| |||
Form 4
|
∞
| 2.16M |
—
|
—
| 2.16M |
Dec 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||